Aaron Gorovitz's most recent trade in NRX Pharmaceuticals Inc was a trade of 162,660 Employee Stock Option done . Disclosure was reported to the exchange on Oct. 21, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
NRX Pharmaceuticals Inc | Aaron Gorovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 162,660 | 162,660 | - | - | Employee Stock Option | |
NRX Pharmaceuticals Inc | Aaron Gorovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 16,678 | 16,678 | - | - | Common Stock | |
NRX Pharmaceuticals Inc | Aaron Gorovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 8,336 | 8,336 | - | - | Common Stock | |
NRX Pharmaceuticals Inc | Aaron Gorovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 8,336 | 8,336 | - | - | Common Stock | |
NRX Pharmaceuticals Inc | Aaron Gorovitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 8,336 | 8,336 | - | - | Common Stock |